Papers/PMID:19020533
The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial.
Journal of human hypertension2009The record
2 findings · 1 compound · 2 endpoints
What it reported
How to read these marksWhat moved
2 findings
magnesium(2+) — decreases diastolic blood pressure (setting unspecified)
Evidence strength: very limited.Findingreplicated ×5“SBP (-20.4+/-15.9 versus -4.7 +/- 12.7 mm Hg, P=0.03) and DBP (-8.7+/-16.3 versus -1.2+/-12.6 mm Hg, P=0.02) showed significant decreases, and high-density lipoprotein-cholesterol (0.1+/-0.6 versus -0.1+/-0.7 mmol l(-1), P=0.04) a significant increase in the magnesium group compared to the placebo group.”
Quoted verbatim from The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial.. - Study
- RCT
- Duration
- 4 months
- Dose
- 2.5 g MgCl2 as oral solution, equivalent to 450 mg elemental magnesium
- Population
- Diabetic hypertensive adults aged 40-75 with hypomagnesaemia, not on diuretics, all receiving captopril
The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial.2009PMID:1902053310.1038/jhh.2008.129Permalink
magnesium(2+) — decreases systolic blood pressure (setting unspecified)
Evidence strength: very limited.Findingreplicated ×5“SBP (-20.4+/-15.9 versus -4.7 +/- 12.7 mm Hg, P=0.03) and DBP (-8.7+/-16.3 versus -1.2+/-12.6 mm Hg, P=0.02) showed significant decreases, and high-density lipoprotein-cholesterol (0.1+/-0.6 versus -0.1+/-0.7 mmol l(-1), P=0.04) a significant increase in the magnesium group compared to the placebo group.”
Quoted verbatim from The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial.. - Study
- RCT
- Duration
- 4 months
- Dose
- 2.5 g MgCl2 as oral solution, equivalent to 450 mg elemental magnesium
- Population
- Diabetic hypertensive adults aged 40-75 with hypomagnesaemia, not on diuretics, all receiving captopril
The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial.2009PMID:1902053310.1038/jhh.2008.129Permalink